Suppr超能文献

NMDA 受体复合物的蛋白-蛋白相互作用:从突触保留到核突触蛋白信使。

Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers.

机构信息

Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy.

Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy.

出版信息

Neuropharmacology. 2021 Jun 1;190:108551. doi: 10.1016/j.neuropharm.2021.108551. Epub 2021 Apr 2.

Abstract

N-methyl-d-aspartate receptors (NMDARs) are glutamate-gated ion channels that support essential functions throughout the brain. NMDARs are tetramers composed of the GluN1 subunit in complex with GluN2- and GluN3-type regulatory subunits, resulting in the formation of various receptor subtypes throughout the central nervous system (CNS), characterised by different kinetics, biophysical and pharmacological properties, and the abilities to interact with specific partners at dendritic spines. NMDARs are expressed at high levels, are widely distributed throughout the brain, and are involved in several physiological and pathological conditions. Here, we will focus on the GluN2A- and GluN2B-containing NMDARs found at excitatory synapses and their interactions with plasticity-relevant proteins, such as the postsynaptic density family of membrane-associated guanylate kinases (PSD-MAGUKs), Ca/calmodulin-dependent kinase II (CaMKII) and synaptonuclear protein messengers. The dynamic interactions between NMDAR subunits and various proteins regulating synaptic receptor retention and synaptonuclear signalling mediated by protein messengers suggest that the NMDAR serves as a key molecular player that coordinates synaptic activity and cell-wide events that require gene transcription. Importantly, protein-protein interactions at the NMDAR complex can also contribute to synaptic dysfunction in several brain disorders. Therefore, the modulation of the molecular composition of the NMDAR complex might represent a novel pharmacological approach for the treatment of certain disease states.

摘要

N-甲基-D-天冬氨酸受体(NMDAR)是谷氨酸门控离子通道,在大脑中支持各种基本功能。NMDAR 由 GluN1 亚基与 GluN2-和 GluN3 型调节亚基组成的四聚体构成,导致中枢神经系统(CNS)中各种受体亚型的形成,其特征为不同的动力学、生物物理和药理学特性,以及与树突棘上特定伴侣相互作用的能力。NMDAR 表达水平高,广泛分布于大脑中,并参与多种生理和病理条件。在这里,我们将重点关注兴奋性突触处存在的含有 GluN2A 和 GluN2B 的 NMDAR 及其与与可塑性相关蛋白的相互作用,如突触后密度家族的膜相关鸟苷酸激酶(PSD-MAGUKs)、钙/钙调蛋白依赖性激酶 II(CaMKII)和核突触蛋白信使。NMDAR 亚基与各种调节突触受体保留和核突触信号的蛋白之间的动态相互作用表明,NMDAR 作为一种关键的分子参与者,协调突触活动和需要基因转录的全细胞事件。重要的是,NMDAR 复合物中的蛋白-蛋白相互作用也可能导致几种脑部疾病中的突触功能障碍。因此,NMDAR 复合物的分子组成的调节可能代表治疗某些疾病状态的一种新的药理学方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验